首页> 外文期刊>Biomaterials >An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineering.
【24h】

An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineering.

机译:各向异性纳米纤维/微球复合材料,具有可控释放的生物分子,用于纤维组织工程。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aligned nanofibrous scaffolds can recapitulate the structural hierarchy of fiber-reinforced tissues of the musculoskeletal system. While these electrospun fibrous scaffolds provide physical cues that can direct tissue formation when seeded with cells, the ability to chemically guide a population of cells, without disrupting scaffold mechanical properties, would improve the maturation of such constructs and add additional functionality to the system both in vitro and in vivo. In this study, we developed a fabrication technique to entrap drug-delivering microspheres within nanofibrous scaffolds. We hypothesized that entrapping microspheres between fibers would have a less adverse impact on mechanical properties than placing microspheres within the fibers themselves, and that the composite would exhibit sustained release of multiple model compounds. Our results show that microspheres ranging from 10 - 20 microns in diameter could be electrospun in a dose-dependent manner to form nanofibrous composites. When delivered in a sacrificial PEO fiber population, microspheres remained securely entrapped between slow-degrading PCL fibers after removal of the sacrificial delivery component. Stiffness and modulus of the composite decreased with increasing microsphere density for composites in which microspheres were entrapped within each fiber, while stiffness did not change when microspheres were entrapped between fibers. The release profiles of the composite structures were similar to free microspheres, with an initial burst release followed by a sustained release of the model molecules over 4 weeks. Further, multiple model molecules were released from a single scaffold composite, demonstrating the capacity for multi-factor controlled release ideal for complex growth factor delivery from these structures.
机译:对齐的纳米纤维支架可以概括肌肉骨骼系统的纤维增强组织的结构层次。尽管这些电纺纤维支架提供了在植入细胞时可以指导组织形成的物理线索,但化学引导细胞群而不破坏支架机械性能的能力将改善此类构建体的成熟度,并为系统增加额外的功能。体外和体内。在这项研究中,我们开发了一种制造技术,可以将药物递送微球包裹在纳米纤维支架中。我们假设在纤维之间截留微球比在纤维本身内放置微球对机械性能的不利影响小,并且复合材料将表现出多种模型化合物的持续释放。我们的结果表明,直径为10-20微米的微球可以剂量依赖性方式进行电纺丝,以形成纳米纤维复合材料。当以牺牲性PEO纤维群的形式递送时,除去牺牲性递送成分后,微球仍牢固地保留在缓慢降解的PCL纤维之间。对于将微球包裹在每根纤维中的复合材料,复合物的刚度和模量随微球密度的增加而降低,而当将微球包裹在纤维之间时,刚性没有变化。复合结构的释放曲线类似于自由微球,最初的突释释放,随后是模型分子在4周内的持续释放。此外,多个模型分子是从单个支架复合物中释放的,这表明了从这些结构中输送复杂生长因子的理想的多因子控制释放能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号